mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-06 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |